Therefore, it is speculated that rs2228145 impairs classical IL-6/IL-6R signaling and reduces the inflammatory response, thus leading to a lower risk of CVDs, inflammatory, or autoimmune diseases (19). The gene discussed is IL6R; the disease is autoimmune disease.